Riskpilot← Back to searchSign inGet full accessC-MEDICUS AB
ABActiveOrg 5591564520Erik Dahlbergsgatan 54Medical specialists activities · NACE 8622Est. 20180 employees
Revenue 2024
SEK 532K
-9% vs 2023
EBITDA margin
90.0%
-12% vs 2023
Equity ratio
74.7%
Financial strength
Net profit 2024
SEK 384K
-11% vs 2023
| Revenue | SEK 532K | -9% |
| EBITDA | SEK 479K | -12% |
| Net profit | SEK 384K | -11% |
| Total assets | SEK 2,5M | -15% |
| Equity | SEK 1,8M | +11% |
| Employees | 0 | — |
Legal name
C-MEDICUS AB
Org number
5591564520
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 april 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva läkarpraktik, utbildning och konsultation inom hälso- och sjukvård samt förvaltning av värdepapper, lös och fast egendom och därmed förenlig verksamhet.
Address
Erik Dahlbergsgatan 54
Email
claes.schuborg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 642 | 783 | 609 | 584 | 532 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 608 | 751 | 567 | 542 | 479 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 608 | 751 | 567 | 542 | 479 |
| Net financials | −1 | −2 | — | 3 | 4 |
| Profit before tax | 607 | 749 | 567 | 545 | 484 |
| Tax | −130 | −155 | −117 | −112 | −100 |
| Net profit | 477 | 594 | 450 | 433 | 384 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 540 | 2 187 | 2 529 | 2 915 | 2 474 |
| Equity | 756 | 1 175 | 1 430 | 1 663 | 1 847 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 784 | 1 013 | 1 099 | 1 252 | 627 |
| Total debt | 784 | 1 013 | 1 099 | 1 252 | 627 |
EBITDA margin
90.0%
This company
15.8%
Market median
+470% vs market
20202024
Equity ratio
74.7%
This company
38.2%
Market median
+96% vs market
20202024
Return on equity
20.8%
This company
18.4%
Market median
+13% vs market
20202024
Net profit margin
72.2%
This company
8.1%
Market median
+791% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of C-MEDICUS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Johan Schuborg | Board of Directors | 0 companies |
| Karin Anna Maria Staffans Schuborg | Deputy Board Member | 0 companies |